TJX Companies
TJX
138.80
+1.77
+1.29%
TJX Companies
US · TJX
#148 by market cap
Listed 1970
138.80
+1.77
+1.29%
Live - 5344 symbols - heartbeat 5s ago
· 2026-10-08 08:29
Pre-market
138.80
0.00%
After-hours
138.65
-0.11%
Overnight
138.65
-0.11%
- Market cap
- 152.68B
- P/E (TTM)i
- 25.70
- P/Bi
- 14.33
- EPSi
- 4.87
- Div yieldi
- 1.26%
- 52W posi
- 34%
Reader sentiment
Are you bullish or bearish on TJX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.36, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +7.12% YoY
Margins
- Gross margin
- 30.96%
- Operating margin
- 11.89%
- Net margin
- 9.10%
Key ratios & quality
- Enterprise valuei
- 151.04B
- PEG ratioi
- 1.58
- Altman Z-Scorei
- 6.36
PEG uses trailing P/E against the 3-year net income growth rate (16.24%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 38.97B | 41.72B | 32.14B | 48.55B | 49.94B | 54.22B | 56.36B | 60.37B |
| Gross profit | 11.14B | 11.87B | 7.60B | 13.84B | 13.79B | 16.27B | 17.25B | 18.69B |
| Selling & admin expenses | 6.92B | 7.45B | 7.02B | 9.08B | 8.93B | 10.47B | 10.95B | 11.52B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 4.22B | 4.42B | 582.00M | 4.76B | 4.86B | 5.80B | 6.30B | 7.18B |
| Pretax profit | 4.17B | 4.41B | 89.00M | 4.40B | 4.64B | 5.97B | 6.48B | 7.30B |
| Tax | 1.11B | 1.13B | -1.00M | 1.12B | 1.14B | 1.49B | 1.62B | 1.81B |
| Net profit | 3.06B | 3.27B | 90.00M | 3.28B | 3.50B | 4.47B | 4.86B | 5.49B |
| Basic EPS | 2 | 3 | 0 | 3 | 3 | 4 | 4 | 5 |
| Diluted EPS | 2.43 | 2.67 | 0.07 | 2.70 | 2.97 | 3.86 | 4.26 | 4.87 |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 13.11B | 14.40B | 15.12B | 17.74B | 14.32B | 15.18B |
| Gross profit | 3.87B | 4.43B | 4.93B | 5.48B | 4.48B | 5.07B |
| Selling & admin expenses | 2.55B | 2.81B | 3.04B | 3.12B | 2.79B | 3.09B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.32B | 1.62B | 1.89B | 2.35B | 1.69B | 1.99B |
| Pretax profit | 1.35B | 1.65B | 1.92B | 2.39B | 1.72B | 2.02B |
| Tax | 310.00M | 404.00M | 474.00M | 617.00M | 389.00M | 498.00M |
| Net profit | 1.04B | 1.24B | 1.44B | 1.77B | 1.33B | 1.52B |
| Basic EPS | 1 | 1 | 1 | 2 | 1 | 1 |
| Diluted EPS | 0.92 | 1.10 | 1.28 | 1.58 | 1.19 | 1.36 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 8.47B | 8.89B | 15.74B | 13.26B | 12.46B | 12.66B | 12.99B | 15.20B |
| Cash & ST investments | 3.03B | 3.22B | 10.47B | 6.23B | 5.48B | 5.60B | 5.34B | 6.23B |
| Inventory | 4.58B | 4.87B | 4.34B | 5.96B | 5.82B | 5.97B | 6.42B | 7.30B |
| Total assets | 14.33B | 24.15B | 30.81B | 28.46B | 28.35B | 29.75B | 31.75B | 35.77B |
| Total current liabilities | 5.53B | 7.15B | 10.80B | 10.47B | 10.31B | 10.45B | 11.01B | 13.36B |
| Short-term debt | -- | 1.41B | 2.43B | 1.58B | 2.11B | 1.62B | 1.64B | 2.73B |
| Long-term debt | 2.23B | 2.24B | 5.33B | 3.36B | 2.86B | 2.86B | 2.87B | 1.87B |
| Total liabilities | 9,277,423,000.00 | 18,196,791,000.00 | 24,980,871,000.00 | 22,458,000,000.00 | 21,985,000,000.00 | 22,445,000,000.00 | 23,356,000,000.00 | 25,577,000,000.00 |
| Total equity | 5.05B | 5.95B | 5.83B | 6.00B | 6.36B | 7.30B | 8.39B | 10.19B |
| Retained earnings | 4.46B | 5.42B | 4.97B | 5.51B | 5.82B | 6.70B | 7.88B | 9.43B |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 12.60B | 13.28B | 15.31B | 15.20B | 14.64B | 15.33B |
| Cash & ST investments | 4.26B | 4.64B | 4.64B | 6.23B | 5.58B | 6.00B |
| Inventory | 7.13B | 7.37B | 9.35B | 7.30B | 7.68B | 7.86B |
| Total assets | 31.86B | 32.89B | 35.19B | 35.77B | 36.16B | 37.12B |
| Total current liabilities | 10.83B | 11.31B | 14.00B | 13.36B | 12.86B | 13.36B |
| Short-term debt | 1.66B | 1.67B | 2.71B | 2.73B | 2.71B | 2.71B |
| Long-term debt | 2.87B | 2.87B | 1.87B | 1.87B | 1.87B | 1.87B |
| Total liabilities | 23,355,000,000.00 | 24,019,000,000.00 | 25,829,000,000.00 | 25,577,000,000.00 | 25,755,000,000.00 | 26,464,000,000.00 |
| Total equity | 8.50B | 8.87B | 9.36B | 10.19B | 10.40B | 10.65B |
| Retained earnings | 7.85B | 8.20B | 8.72B | 9.43B | 9.67B | 9.97B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.09B | 4.07B | 4.56B | 3.06B | 4.08B | 6.06B | 6.12B | 6.87B |
| Depreciation & amortization | 819.66M | 867.30M | 871.00M | 868.00M | 887.00M | 964.00M | 1.10B | 1.25B |
| Free cash flow | 2.96B | 2.84B | 3.99B | 2.01B | 2.63B | 4.34B | 4.20B | 4.92B |
| Dividends paid | -922.60M | -1.07B | -278.00M | -1.25B | -1.34B | -1.48B | -1.65B | -1.84B |
| Stock buybacks / issuance | -2.15B | -1.32B | 9.00M | -1.95B | -1.93B | -2.20B | -2.15B | -2.21B |
| Ending cash balance | 3.03B | 3.22B | 10.47B | 6.23B | 5.48B | 5.60B | 5.34B | 6.23B |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 394.00M | 1.79B | 1.53B | 3.16B | 1.12B | 2.23B |
| Depreciation & amortization | 296.00M | 308.00M | 316.00M | 327.00M | 336.00M | 340.00M |
| Free cash flow | -103.00M | 1.33B | 1.00B | 2.69B | 457.00M | 1.73B |
| Dividends paid | -424.00M | -474.00M | -473.00M | -471.00M | -474.00M | -531.00M |
| Stock buybacks / issuance | -563.00M | -477.00M | -502.00M | -669.00M | -534.00M | -750.00M |
| Ending cash balance | 4.26B | 4.64B | 4.64B | 6.23B | 5.58B | 6.00B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 60.01 | 59.51 | 1.54 | 55.47 | 56.57 | 65.48 | 61.98 | 59.13 |
| ROA %i | 21.56 | 17.01 | 0.33 | 11.08 | 12.31 | 15.40 | 15.82 | 16.27 |
| ROIC %i | 40.54 | 24.89 | 1.15 | 16.91 | 18.62 | 22.32 | 23.06 | 24.09 |
| 5-year avg ROE %i | 54.29 | 55.76 | 45.44 | 46.11 | 46.62 | 47.71 | 48.21 | 59.73 |
| EBIT margin %i | 10.87 | 10.70 | 0.88 | 9.30 | 9.45 | 11.15 | 11.64 | 12.21 |
| FCF / sales %i | 7.60 | 6.82 | 12.43 | 4.15 | 5.26 | 8.00 | 7.45 | 8.14 |
| Current ratioi | 1.53 | 1.24 | 1.46 | 1.27 | 1.21 | 1.21 | 1.18 | 1.14 |
| Quick ratioi | 0.61 | 0.51 | 1.02 | 0.66 | 0.60 | 0.59 | 0.54 | 0.51 |
| Debt / assetsi | 17.29 | 47.48 | 50.31 | 43.95 | 44.95 | 42.16 | 40.25 | 37.71 |
| LT debt / equityi | 49.06 | 169.01 | 224.19 | 182.09 | 167.10 | 149.58 | 132.75 | 105.63 |
| Interest coveragei | 65.36 | 75.57 | 1.46 | 37.80 | 56.19 | 76.53 | 86.30 | 99.64 |
| Revenue CAGR (3Y) %i | 7.99 | 7.93 | -3.59 | 7.60 | 6.18 | 19.04 | 5.10 | 6.53 |
| Net income CAGR (3Y) %i | 10.34 | 12.50 | -67.44 | 2.37 | 2.25 | 267.69 | 14.00 | 16.24 |
| FCF CAGR (3Y) %i | 12.75 | 3.00 | 26.61 | -12.11 | -2.60 | 2.77 | 27.78 | 23.24 |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 60.36 | 59.75 | 58.40 | 59.13 | 61.25 | 62.17 |
| ROA %i | 15.70 | 15.68 | 15.14 | 16.27 | 17.03 | 17.33 |
| ROIC %i | 22.58 | 22.95 | 23.13 | 24.09 | 24.68 | 25.42 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.43 | 11.55 | 11.65 | 12.21 | 12.58 | 13.02 |
| FCF / sales %i | 6.63 | 6.98 | 7.49 | 8.14 | 8.89 | 9.42 |
| Current ratioi | 1.16 | 1.17 | 1.09 | 1.14 | 1.14 | 1.15 |
| Quick ratioi | 0.45 | 0.47 | 0.38 | 0.51 | 0.49 | 0.50 |
| Debt / assetsi | 41.00 | 39.90 | 37.50 | 37.71 | 39.22 | 38.57 |
| LT debt / equityi | 134.09 | 129.17 | 112.04 | 105.63 | 110.23 | 108.94 |
| Interest coveragei | 86.85 | 91.66 | 95.42 | 99.64 | 104.70 | 108.27 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Marmaxx is the largest reported line at 60.01% of revenue, across 4 reported segments.
- HomeGoods follows at 16.52%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Marmaxx60.01%
HomeGoods16.52%
TJX International13.79%
TJX Canada9.68%
Quote time 2026-10-08 08:29:46 · For reference only, not investment advice and not tailored to your situation.